These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25459584)

  • 21. Treatment of Allergic Rhinitis.
    Sur DK; Plesa ML
    Am Fam Physician; 2015 Dec; 92(11):985-92. PubMed ID: 26760413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic rhinitis.
    Bousquet J; Anto JM; Bachert C; Baiardini I; Bosnic-Anticevich S; Walter Canonica G; Melén E; Palomares O; Scadding GK; Togias A; Toppila-Salmi S
    Nat Rev Dis Primers; 2020 Dec; 6(1):95. PubMed ID: 33273461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mepolizumab use: Post-approval academic practice experience.
    Benjamin MR; Bochner BS; Peters AT
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):126-128. PubMed ID: 29653234
    [No Abstract]   [Full Text] [Related]  

  • 24. [The value of omazulimab in the treatment of severe asthma].
    Miao WW; Wang FF; Li HY
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Mar; 35(3):198-200. PubMed ID: 22781153
    [No Abstract]   [Full Text] [Related]  

  • 25. Local Allergic Rhinitis.
    Campo P; Salas M; Blanca-López N; Rondón C
    Immunol Allergy Clin North Am; 2016 May; 36(2):321-32. PubMed ID: 27083105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study.
    Di Rienzo V; Cadario G; Grieco T; Galluccio AG; Caffarelli C; Liotta G; Pecora S; Burastero SE
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):671-673.e1. PubMed ID: 25304342
    [No Abstract]   [Full Text] [Related]  

  • 27. Omalizumab for treatment of allergic rhinitis.
    Vashisht P; Casale T
    Expert Opin Biol Ther; 2013 Jun; 13(6):933-45. PubMed ID: 23621175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergic rhinitis.
    Nat Rev Dis Primers; 2020 Dec; 6(1):96. PubMed ID: 33273472
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Poorly controlled asthma: diagnosis and therapeutics in children and adolescents].
    Neffen H; Vidaurreta S; Balanzat A; De Gennaro MS; Giubergia V; Maspero JF; Saranz RJ; Teper AM
    Medicina (B Aires); 2012; 72(5):403-13. PubMed ID: 23089117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-IgE for the treatment of allergic rhinitis--and eventually nasal polyps?
    Verbruggen K; Van Cauwenberge P; Bachert C
    Int Arch Allergy Immunol; 2009; 148(2):87-98. PubMed ID: 18799888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
    Tzortzaki EG; Georgiou A; Kampas D; Lemessios M; Markatos M; Adamidi T; Samara K; Skoula G; Damianaki A; Schiza S; Tzanakis N; Siafakas NM
    Pulm Pharmacol Ther; 2012 Feb; 25(1):77-82. PubMed ID: 22155001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of remission of idiopathic anaphylaxis with rituximab.
    Borzutzky A; Morales PS; Mezzano V; Nussbaum S; Burks AW
    J Allergy Clin Immunol; 2014 Oct; 134(4):981-3. PubMed ID: 25018095
    [No Abstract]   [Full Text] [Related]  

  • 34. Omalizumab (Xolair): an anti-IgE antibody for asthma.
    Med Lett Drugs Ther; 2003 Aug; 45(1163):67-8. PubMed ID: 12915804
    [No Abstract]   [Full Text] [Related]  

  • 35. Omalizumab and the immune system: an overview of preclinical and clinical data.
    Johansson SG; Haahtela T; O'Byrne PM
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):132-8. PubMed ID: 12197568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma.
    Tajiri T; Matsumoto H; Hiraumi H; Ikeda H; Morita K; Izuhara K; Ono J; Ohta S; Ito I; Oguma T; Nakaji H; Inoue H; Iwata T; Nagasaki T; Kanemitsu Y; Ito J; Niimi A; Mishima M
    Ann Allergy Asthma Immunol; 2013 May; 110(5):387-8. PubMed ID: 23622013
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain.
    Ibáñez MD; Valero AL; Montoro J; Jauregui I; Ferrer M; Dávila I; Bartra J; Del Cuvillo A; Mullol J; Sastre J
    Pediatr Allergy Immunol; 2013 Nov; 24(7):678-84. PubMed ID: 24028473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Food and environmental allergies.
    Huffman MM
    Prim Care; 2015 Mar; 42(1):113-28. PubMed ID: 25634709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs for allergic disorders.
    Med Lett Drugs Ther; 2017 May; 59(1520):71-80. PubMed ID: 28463950
    [No Abstract]   [Full Text] [Related]  

  • 40. [Definition and clinic of the allergic rhinitis].
    Spielhaupter M
    Med Monatsschr Pharm; 2016 Mar; 39(3):97-9. PubMed ID: 27120868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.